HESG (Health Sciences Group) Ending Cash Position: $0.00 Mil (As of Sep. 2006)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Sciences Group Ending Cash Position?

Health Sciences Group HESG -99.00% Ending Cash Position is $0.00 Mil as of Sep. 2006.

Health Sciences Group's Ending Cash Position for the quarter that ended in Sep. 2006 was $0.00 Mil.

Health Sciences Group's quarterly Ending Cash Position declined from Mar. 2006 ($0.03 Mil) to Jun. 2006 ($0.01 Mil) and declined from Jun. 2006 ($0.01 Mil) to Sep. 2006 ($0.00 Mil).

Health Sciences Group's annual Ending Cash Position declined from Dec. 2003 ($0.27 Mil) to Dec. 2004 ($0.24 Mil) and declined from Dec. 2004 ($0.24 Mil) to Dec. 2005 ($0.02 Mil).


Health Sciences Group Ending Cash Position Related Terms


Health Sciences Group Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Health Sciences Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Sciences Group Ending Cash Position Chart

Health Sciences Group Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Ending Cash Position
Get a 7-Day Free Trial 0.00 0.17 0.27 0.24 0.02

Health Sciences Group Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.02 0.03 0.01 0.00

Health Sciences Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Health Sciences Group's Ending Cash Position for the fiscal year that ended in Dec. 2005 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.24+-0.219
=0.02

Health Sciences Group's Ending Cash Position for the quarter that ended in Sep. 2006 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.007+-0.005
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.00 Mil mean?
Health Sciences Group (HESG) has a Ending Cash Position of $0.00 Mil as of Sep. 2006. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Health Sciences Group and its competitors.
Is Health Sciences Group's Ending Cash Position too high?
Health Sciences Group's current Ending Cash Position is $0.00 Mil.
How does Health Sciences Group's Ending Cash Position compare to VITIF and HSTC?
Health Sciences Group's Ending Cash Position of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Health Sciences Group and its competitors. Health Sciences Group's current Ending Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Sciences Group stock overvalued right now?
Health Sciences Group (HESG) has a current Ending Cash Position of $0.00 Mil. The current Ending Cash Position is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Health Sciences Group (HESG), the current Ending Cash Position is $0.00 Mil as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Sciences Group Business Description

Address 14331 Euclid Street, Suite 207, Garden Grove, CA, USA, 92843
Health Sciences Group Inc identifies, develops, and commercializes nutritional products. Its products are targeted towards consumers and medical professionals interested in preventative healthcare alternatives. The products are sold as nutritional supplements and functional ingredients to retail and wholesale customers in the nutrition, skin care, and food industries. The company distributes its products under the Swiss Research and Swiss Diet brand names.